In-utero tenofovir-based PrEP has no effect on children’s bone mineral density
25 September 2023. Related: Early access, Conference reports, Pregnancy, Paediatric care, HIV prevention and transmission.
IAS 2023 Brisbane
High rates of re-suppression with dolutegravir in the ADVANCE study
19 September 2023. Related: Early access, Conference reports, Treatment strategies, Drug resistance.
12th IAS Conference on HIV Science (IAS 2023): further reports
1 September 2023. Related: Conference reports.
IAS 2023: Update to navigating the programme and online access
1 September 2023. Related: Conference reports.
IAS 2023: Metabolic and weight changes using GLP-1 agonists in people living with HIV: need for more data
1 September 2023. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
IAS 2023: Rapporteur summary track A – basic science
1 September 2023. Related: Conference reports, Cure research, Basic science and immunology, Vaccines and microbicides.
IAS 2023: Rapporteur summary track C – prevention
1 September 2023. Related: Conference reports, HIV prevention and transmission.
IAS 2023: Rapporteur summary track D – social and behavioural science
1 September 2023. Related: Conference reports, Treatment strategies.
12th IAS Conference on HIV Science (IAS 2023)
1 August 2023. Related: Conference reports.
IAS 2023: Update to navigate the programme and online access
1 August 2023. Related: Conference reports.
WHO endorses “zero” transmission risk for people with HIV with an undetectable viral load
1 August 2023. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
Viral load level when suppressed <1000 predicts future rebound: 3-monthly monitoring required
1 August 2023. Related: Conference reports, HIV prevention and transmission.
ART-associated hypertension can be successfully treated in African settings
1 August 2023. Related: Conference reports, Side effects, Coinfections and complications.
REPRIEVE study: statin benefits people living with HIV at low to moderate CVD risk
1 August 2023. Related: Conference reports, Coinfections and complications.
Geneva patient and other HIV cure research at IAS 2023
1 August 2023. Related: Conference reports, Cure research.
Guide to other HIV cure-related research at IAS 2023
1 August 2023. Related: Conference reports.
Rapporteur summaries: track B clinical science
1 August 2023. Related: Conference reports, Antiretrovirals.
Early press conference: cure, gay circumcision, PrEP choices, mpox, and COVID-19
1 August 2023. Related: Conference reports, mpox (monkeypox), HIV prevention and transmission, Cure research, COVID-19: HIV and COVID-19 coinfection, COVID-19.